May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!

Community Symposium Agenda

Community Symposium on the Molecular Basis of ME / CFS at Stanford University

Sponsored by OMF

Saturday, August 12, 2017

Registration begins 8 AM; Conference 9 AM – 5 PM; Reception 5PM – 6PM (all Pacific Time)

Agenda

08:00 a.m. Registration
09:00 a.m. Welcome: Linda Tannenbaum, CEO, OMF
09:03 a.m. Symposium Logistics: Ashley Haugen, Event Organizer
09:05 a.m. Opening Remarks – Ronald W. Davis, PhD, Stanford University
09:10 a.m. Keynote Speech – Robert K. Naviaux, MD, PhD, University of California, San Diego
The metabolism of the cell danger response, healing, and ME / CFS
09:30 a.m. Chris Armstrong, University of Melbourne
ME, metabolism and I
09:50 a.m. Jonas Bergquist, MD, PhD, Uppsala University
In search of biomarkers revealing pathophysiology in a Swedish ME / CFS patient cohort

Coffee break

10:40 a.m. Maureen Hanson, PhD, Cornell University
Probing metabolism in ME / CFS
11:00 a.m. Neil McGregor, MDSc, PhD, University of Melbourne
Genome-wide analysis & metabolome changes in ME / CFS
11:20 a.m. Alan Light, PhD, University of Utah
Gene variants, mitochondria & autoimmunity in ME / CFS
11:40 a.m. Panel Discussion – Morning Speakers

Lunch

01:30 p.m. Baldomero Olivera, PhD, Howard Hughes Medical Institute and University of Utah
A novel source of drugs: the biodiversity of oceans
01:50 p.m. Mario Capecchi, PhD, Nobel laureate, University of Utah
The role of microglia in neuropsychiatric disorders
02:10 p.m. Mark Davis, PhD, Howard Hughes Medical Institute and Stanford University
Is CFS/ME an autoimmune disease?

Coffee break

03:00 p.m. Alain Moreau, PhD, University of Montreal
New research strategies for decoding ME / CFS to improve diagnosis and treatment
03:20 p.m. Wenzhong Xiao, PhD, Massachusetts General Hospital and Harvard Medical School
Big data analysis of patient studies of ME / CFS
03:40 p.m. Ronald W. Davis, Stanford University
Establishing new mechanistic and diagnostic paradigms for ME / CFS
04:00 p.m. Panel Discussion – Afternoon Speakers
04:30 p.m.
Closing Remarks: Linda Tannenbaum, OMF, CEO
Ronald W. Davis, PhD

Reception